而根据“士泽生物”微信公众号，此次公司正式由国家两委局获批开展的临床研究，采用自主开发的用于治疗渐冻症的临床级iPSC衍生亚型神经前体 ...

Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates - ...